Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 1:10 pm Sale | 2025-09-30 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Cormorant Asset Management, LP | 0 0.000% | -1,370,938 (Position Closed) | Filing History |
| 2025-11-14 1:09 pm Purchase | 2025-09-30 | 13G | RAPPORT THERAPEUTICS INC RAPP | Cormorant Asset Management, LP | 3,192,521 6.700% | 251,600 (+8.56%) | Filing History |
| 2025-11-14 1:08 pm Sale | 2025-09-30 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Cormorant Asset Management, LP | 1,000,000 4.000% | -625,000 (-38.46%) | Filing History |
| 2025-11-14 1:07 pm Sale | 2025-09-30 | 13G | KALA BIO, INC. KALA | Cormorant Asset Management, LP | 0 0.000% | -12,181 (Position Closed) | Filing History |
| 2025-11-14 1:07 pm Purchase | 2025-09-30 | 13G | IBIO INC PAR $0.001 IBIO | Cormorant Asset Management, LP | 2,248,010 9.990% | 2,248,010 (New Position) | Filing History |
| 2025-10-24 4:10 pm Sale | 2025-10-22 | 13D | BIOMEA FUSION INC BMEA | Cormorant Asset Management, LP | 1,060,792 1.530% | -2,620,872 (-71.19%) | Filing History |
| 2025-10-10 4:06 pm Unchanged | 2025-10-08 | 13D | BIOMEA FUSION INC BMEA | Cormorant Asset Management, LP | 3,681,664 5.310% | 0 (Unchanged) | Filing History |
| 2025-08-14 3:04 pm Sale | 2025-06-30 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Cormorant Asset Management, LP | 1,370,938 8.230% | -478,652 (-25.88%) | Filing History |
| 2025-08-14 3:03 pm Sale | 2025-06-30 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Cormorant Asset Management, LP | 1,625,000 7.720% | -120,000 (-6.88%) | Filing History |
| 2025-08-14 3:02 pm Purchase | 2025-06-30 | 13G | CABALETTA BIO INC CABA | Cormorant Asset Management, LP | 5,000,000 5.470% | 5,000,000 (New Position) | Filing History |
| 2025-08-14 3:01 pm Sale | 2025-06-30 | 13G | BIOAGE LABS INC BIOA | Cormorant Asset Management, LP | 2,140,605 5.970% | -488,924 (-18.59%) | Filing History |
| 2025-07-22 5:15 pm Purchase | 2025-06-20 | 13D | BIOMEA FUSION INC BMEA | Cormorant Asset Management, LP | 3,681,664 6.460% | 3,681,664 (New Position) | Filing History |
| 2025-05-19 5:47 pm Purchase | 2025-03-31 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Cormorant Asset Management, LP | 1,849,590 9.990% | 1,849,590 (New Position) | Filing History |
| 2025-05-19 3:02 pm Sale | 2025-05-15 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Cormorant Asset Management, LP | 0 0.000% | -1,837,739 (Position Closed) | Filing History |
| 2025-05-15 3:03 pm Sale | 2025-03-31 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Cormorant Asset Management, LP | 0 0.000% | -1,394,336 (Position Closed) | Filing History |
| 2025-05-15 3:01 pm Purchase | 2025-03-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Cormorant Asset Management, LP | 1,745,000 8.570% | 51,781 (+3.06%) | Filing History |
| 2025-05-15 3:00 pm Purchase | 2025-03-31 | 13G | CARGO THERAPEUTICS INC CRGX | Cormorant Asset Management, LP | 3,381,277 7.330% | 3,381,277 (New Position) | Filing History |
| 2025-02-14 3:03 pm Purchase | 2024-12-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Cormorant Asset Management, LP | 1,693,219 9.080% | 553,219 (+48.53%) | Filing History |
| 2025-02-14 3:01 pm Purchase | 2024-12-31 | 13G | KALA BIO, INC. KALA | Cormorant Asset Management, LP | 12,181 9.990% | 12,181 (New Position) | Filing History |
| 2025-02-14 3:00 pm Purchase | 2024-12-31 | 13G | BIOAGE LABS INC BIOA | Cormorant Asset Management, LP | 2,629,529 7.340% | 2,629,529 (New Position) | Filing History |